{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:08:36Z","timestamp":1795068516941,"version":"4.10.2"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Region Centre Val de Loire","award":["FLU-MET 2018-00124196"],"award-info":[{"award-number":["FLU-MET 2018-00124196"]}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","award":["EuroFERI"],"award-info":[{"award-number":["EuroFERI"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE18-0061"],"award-info":[{"award-number":["ANR-21-CE18-0061"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-ASTR-0021"],"award-info":[{"award-number":["ANR-22-ASTR-0021"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Annual recurrent budget"],"award-info":[{"award-number":["Annual recurrent budget"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tours university","award":["Annual recurrent budget"],"award-info":[{"award-number":["Annual recurrent budget"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The influenza virus poses a significant global health challenge, causing approximately 500,000 deaths annually. Its ability to evade antiviral treatments and vaccine-induced immunity underscores the need for novel therapeutic approaches. Our study identifies\n                    <jats:italic>cis<\/jats:italic>\n                    -aconitate (\n                    <jats:italic>cis<\/jats:italic>\n                    -aco), a mitochondria-derived metabolite, as a potent dual-action agent against influenza, independently of its metabolic derivative, itaconate.\n                    <jats:italic>Cis<\/jats:italic>\n                    -aco impairs viral polymerase activity, resulting in decreased viral mRNA expression and protein synthesis, as observed for the influenza A\/Scotland\/20\/74 (H3N2) strain. This antiviral effect was further confirmed across multiple influenza A and B strains, as well as in ex vivo human airway and lung organotypic models. Beyond its antiviral properties,\n                    <jats:italic>cis-<\/jats:italic>\n                    aco exhibits potent anti-inflammatory effects, disrupting key inflammatory cascades and reducing the secretion of inflammatory mediators. In a mouse model of influenza pneumonia,\n                    <jats:italic>cis<\/jats:italic>\n                    -aco mitigates viral replication, inflammation, and immune cell activation, significantly improving survival. Notably, its efficacy persists even when administered at later stages of infection, when oseltamivir\/Tamiflu\u00ae is no longer effective. These findings position\n                    <jats:italic>cis<\/jats:italic>\n                    -aco as a promising influenza treatment, combining antiviral and anti-inflammatory benefits within a clinically relevant timeframe.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00379-8","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:02:51Z","timestamp":1771257771000},"page":"1023-1053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK\/AKT\/NF-\u03baB signaling"],"prefix":"10.1038","volume":"18","author":[{"given":"Adeline","family":"Cezard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Brea-Diakite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Vasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-5328","authenticated-orcid":false,"given":"Alan","family":"Wacquiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-3332","authenticated-orcid":false,"given":"Loic","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Le Goffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4860-1448","authenticated-orcid":false,"given":"Ambre","family":"Tinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4179-7997","authenticated-orcid":false,"given":"Delphine","family":"Fouquenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Heumel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Machelart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-1091","authenticated-orcid":false,"given":"Eik","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-7344","authenticated-orcid":false,"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Trottein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-2029","authenticated-orcid":false,"given":"Cyrille","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Canus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentine","family":"Jacolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Vidalain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-6733","authenticated-orcid":false,"given":"Laure","family":"Perrin-Cocon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lotteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Burlaud-Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Tertigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Surette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Legras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Sizaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-0937","authenticated-orcid":false,"given":"Thomas","family":"Baranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-5407","authenticated-orcid":false,"given":"Christophe","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-7742","authenticated-orcid":false,"given":"Mustapha","family":"Si-Tahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"379_CR1","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1039\/D0CS01118E","volume":"50","author":"CS Adamson","year":"2021","unstructured":"Adamson CS, Chibale K, Goss RJM, Jaspars M, Newman DJ, Dorrington RA (2021) Antiviral drug discovery: preparing for the next pandemic. Chem Soc Rev 50:3647\u20133655","journal-title":"Chem Soc Rev"},{"key":"379_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","volume":"398","author":"S Aliberti","year":"2021","unstructured":"Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI (2021) Community-acquired pneumonia. Lancet 398:906\u2013919","journal-title":"Lancet"},{"key":"379_CR73","doi-asserted-by":"crossref","unstructured":"Banat H, Ambrus R, Cs\u00f3ka I (2023) Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance. Int J Pharm 643:123070","DOI":"10.1016\/j.ijpharm.2023.123070"},{"key":"379_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1165\/rcmb.2018-0247TR","volume":"60","author":"KH Benam","year":"2019","unstructured":"Benam KH, Denney L, Ho L-P (2019) How the Respiratory epithelium senses and reacts to influenza virus. Am J Respir Cell Mol Biol 60:259\u2013268","journal-title":"Am J Respir Cell Mol Biol"},{"key":"379_CR4","doi-asserted-by":"publisher","first-page":"L689","DOI":"10.1152\/ajplung.00314.2015","volume":"310","author":"F Blanc","year":"2016","unstructured":"Blanc F, Furio L, Moisy D, Yen H-L, Chignard M, Letavernier E, Naffakh N, Mok CKP, Si-Tahar M (2016) Targeting host calpain proteases decreases influenza A virus infection. Am J Physiol Lung Cell Mol Physiol 310:L689\u2013L699","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"379_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1074\/jbc.M113.469239","volume":"289","author":"Y B\u00f6rgeling","year":"2014","unstructured":"B\u00f6rgeling Y, Schmolke M, Viemann D, Nordhoff C, Roth J, Ludwig S (2014) Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection. J Biol Chem 289:13\u201327","journal-title":"J Biol Chem"},{"key":"379_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/v12030344","volume":"12","author":"P Botwina","year":"2020","unstructured":"Botwina P, Owczarek K, Rajfur Z, Ochman M, Urlik M, Nowakowska M, Szczubia\u0142ka K, Pyrc K (2020) Berberine hampers influenza A replication through inhibition of MAPK\/ERK pathway. Viruses 12:344","journal-title":"Viruses"},{"key":"379_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","volume":"183","author":"C Brun-Buisson","year":"2011","unstructured":"Brun-Buisson C, Richard J-CM, Mercat A, Thi\u00e9baut ACM, Brochard L, REVA-SRLF A\/H1N1v 2009 Registry Group (2011) Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 183:1200\u20131206","journal-title":"Am J Respir Crit Care Med"},{"key":"379_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.antiviral.2013.08.023","volume":"100","author":"AJ Burnham","year":"2013","unstructured":"Burnham AJ, Baranovich T, Govorkova EA (2013) Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance. Antivir Res 100:520\u2013534","journal-title":"Antivir Res"},{"key":"379_CR9","unstructured":"Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases (NCIRD) (2021) Influenza (flu). (https:\/\/www.cdc.gov\/ncird\/flu.html)"},{"key":"379_CR10","unstructured":"Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases (NCIRD) (2025) Types of influenza viruses. (https:\/\/www.cdc.gov\/flu\/about\/viruses\/types.htm)"},{"key":"379_CR11","doi-asserted-by":"publisher","first-page":"100885","DOI":"10.1016\/j.jbc.2021.100885","volume":"297","author":"C Chevalier","year":"2021","unstructured":"Chevalier C, Leymarie O, Sedano L, Da Costa B, Richard C-A, Maisonnasse P, R\u00e9fregiers M, Jamme F, Le Goffic R (2021) PB1-F2 amyloid-like fibers correlate with proinflammatory signaling and respiratory distress in influenza-infected mice. J Biol Chem 297:100885","journal-title":"J Biol Chem"},{"key":"379_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/EBC20200018","volume":"64","author":"N Chiang","year":"2020","unstructured":"Chiang N, Serhan CN (2020) Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 64:443\u2013462","journal-title":"Essays Biochem"},{"key":"379_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11427-010-4116-z","volume":"54","author":"X Dai","year":"2011","unstructured":"Dai X, Zhang L, Hong T (2011) Host cellular signaling induced by influenza virus. Sci China Life Sci 54:68\u201374","journal-title":"Sci China Life Sci"},{"key":"379_CR14","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3389\/fimmu.2018.01946","volume":"9","author":"S Davidson","year":"2018","unstructured":"Davidson S (2018) Treating influenza infection, from now and into the future. Front Immunol 9:1946","journal-title":"Front Immunol"},{"key":"379_CR15","doi-asserted-by":"publisher","first-page":"e1009887","DOI":"10.1371\/journal.ppat.1009887","volume":"17","author":"A Demars","year":"2021","unstructured":"Demars A, Vitali A, Comein A, Carlier E, Azouz A, Goriely S, Smout J, Flamand V, Van Gysel M, Wouters J et al (2021) Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in mice. PLoS Pathog 17:e1009887","journal-title":"PLoS Pathog"},{"key":"379_CR16","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"P-F Dequin","year":"2023","unstructured":"Dequin P-F, Meziani F, Quenot J-P, Kamel T, Ricard J-D, Badie J, Reignier J, Heming N, Plantef\u00e8ve G, Souweine B et al (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 388:1931\u20131941","journal-title":"N Engl J Med"},{"key":"379_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ecco-jcc\/jjad143","volume":"18","author":"J Dhaliwal","year":"2024","unstructured":"Dhaliwal J, Tertigas D, Carman N, Lawrence S, Debruyn JC, Wine E, Church PC, Huynh HQ, Rashid M, El-Matary W et al (2024) Outcomes following acute severe colitis at initial presentation: a multi-centre, prospective, paediatric cohort study. J Crohns Colitis 18:233\u2013245","journal-title":"J Crohns Colitis"},{"key":"379_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep45723","volume":"7","author":"Y Ding","year":"2017","unstructured":"Ding Y, Cao Z, Cao L, Ding G, Wang Z, Xiao W (2017) Antiviral activity of chlorogenic acid against influenza A (H1N1\/H3N2) virus and its inhibition of neuraminidase. Sci Rep 7:45723","journal-title":"Sci Rep"},{"key":"379_CR19","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","volume":"9","author":"D Dou","year":"2018","unstructured":"Dou D, Revol R, \u00d6stbye H, Wang H, Daniels R (2018) Influenza A virus cell entry, replication, virion assembly and movement. Front Immunol 9:1581","journal-title":"Front Immunol"},{"key":"379_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26096-z","volume":"12","author":"M Ferren","year":"2021","unstructured":"Ferren M, Fav\u00e8de V, Decimo D, Iampietro M, Lieberman NAP, Weickert J-L, Pelissier R, Mazelier M, Terrier O, Moscona A et al (2021) Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection. Nat Commun 12:5809","journal-title":"Nat Commun"},{"key":"379_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(24)01307-2","volume":"404","author":"Y Gao","year":"2024","unstructured":"Gao Y, Guyatt G, Uyeki TM, Liu M, Chen Y, Zhao Y, Shen Y, Xu J, Zheng Q, Li Z et al (2024) Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. Lancet 404:753\u2013763","journal-title":"Lancet"},{"key":"379_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s15010-021-01694-7","volume":"50","author":"D Garot","year":"2022","unstructured":"Garot D, Tchatat Wangueu L, Larrat C, Guillon A (2022) Mechanically ventilated COVID-19 patients failed to meet the criteria for the Berlin definition of ARDS. Infection 50:545\u2013546","journal-title":"Infection"},{"key":"379_CR23","doi-asserted-by":"publisher","first-page":"RA148","DOI":"10.12659\/MSM.881801","volume":"17","author":"P Gaur","year":"2011","unstructured":"Gaur P, Munjhal A, Lal SK (2011) Influenza virus and cell signaling pathways. Med Sci Monit 17:RA148\u2013RA154","journal-title":"Med Sci Monit"},{"key":"379_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/bjc.2014.166","volume":"111","author":"RJ Geraghty","year":"2014","unstructured":"Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, Lovell-Badge R, Masters JRW, Meredith J, Stacey GN et al (2014) Guidelines for the use of cell lines in biomedical research. Br J Cancer 111:1021\u20131046","journal-title":"Br J Cancer"},{"key":"379_CR25","doi-asserted-by":"publisher","first-page":"133042","DOI":"10.1172\/jci.insight.133042","volume":"5","author":"A Guillon","year":"2020","unstructured":"Guillon A, Arafa EI, Barker KA, Belkina AC, Martin I, Shenoy AT, Wooten AK, Lyon De Ana C, Dai A, Labadorf A et al (2020) Pneumonia recovery reprograms the alveolar macrophage pool. JCI Insight 5:133042","journal-title":"JCI Insight"},{"key":"379_CR26","doi-asserted-by":"publisher","first-page":"e108306","DOI":"10.15252\/embj.2021108306","volume":"41","author":"A Guillon","year":"2022","unstructured":"Guillon A, Brea-Diakite D, Cezard A, Wacquiez A, Baranek T, Bourgeais J, Picou F, Vasseur V, Meyer L, Chevalier C et al (2022) Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein. EMBO J 41:e108306","journal-title":"EMBO J"},{"key":"379_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.antiviral.2017.03.024","volume":"142","author":"E Haasbach","year":"2017","unstructured":"Haasbach E, M\u00fcller C, Ehrhardt C, Schreiber A, Pleschka S, Ludwig S, Planz O (2017) The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo. Antivir Res 142:178\u2013184","journal-title":"Antivir Res"},{"key":"379_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00134-017-4953-3","volume":"44","author":"R Hernu","year":"2018","unstructured":"Hernu R, Chroboczek T, Madelaine T, Casalegno J-S, Lina B, Cour M, Argaud L, On behalf the \u201cFlu in Lyon ICUs\u201d Study Group (2018) Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis. Intensive Care Med 44:257\u2013260","journal-title":"Intensive Care Med"},{"key":"379_CR29","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1183\/09031936.00186214","volume":"45","author":"S Herold","year":"2015","unstructured":"Herold S, Becker C, Ridge KM, Budinger GRS (2015) Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 45:1463\u20131478","journal-title":"Eur Respir J"},{"key":"379_CR30","doi-asserted-by":"publisher","DOI":"10.4110\/in.2020.20.e32","volume":"20","author":"E-H Hong","year":"2020","unstructured":"Hong E-H, Song J-H, Kim S-R, Cho J, Jeong B, Yang H, Jeong J-H, Ahn J-H, Jeong H, Kim S-E et al (2020) Morin hydrate inhibits influenza virus entry into host cells and has anti-inflammatory effect in influenza-infected mice. Immune Netw 20:e32","journal-title":"Immune Netw"},{"key":"379_CR31","doi-asserted-by":"publisher","first-page":"575, 577","DOI":"10.2144\/000112598","volume":"43","author":"P Hughes","year":"2007","unstructured":"Hughes P, Marshall D, Reid Y, Parkes H, Gelber C (2007) The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?. Biotechniques 43:575, 577\u2013578","journal-title":"Biotechniques"},{"key":"379_CR32","first-page":"CD008965","volume":"2014","author":"T Jefferson","year":"2014","unstructured":"Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D et al (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014:CD008965","journal-title":"Cochrane Database Syst Rev"},{"key":"379_CR33","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1164\/rccm.201101-0110OC","volume":"183","author":"S-H Kim","year":"2011","unstructured":"Kim S-H, Hong S-B, Yun S-C, Choi W-I, Ahn J-J, Lee YJ, Lee H-B, Lim C-M, Koh Y, Korean Society of Critical Care Medicine H1N1 Collaborative (2011) Corticosteroid treatment in critically ill patients with pandemic influenza A\/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 183:1207\u20131214","journal-title":"Am J Respir Crit Care Med"},{"key":"379_CR34","doi-asserted-by":"publisher","first-page":"1162889","DOI":"10.3389\/fphar.2023.1162889","volume":"14","author":"M Lam","year":"2023","unstructured":"Lam M, Lamanna E, Organ L, Donovan C, Bourke JE (2023) Perspectives on precision cut lung slices-powerful tools for investigation of mechanisms and therapeutic targets in lung diseases. Front Pharm 14:1162889","journal-title":"Front Pharm"},{"key":"379_CR35","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1371\/journal.ppat.0020053","volume":"2","author":"R Le Goffic","year":"2006","unstructured":"Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M (2006) Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2:e53","journal-title":"PLoS Pathog"},{"key":"379_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/BF02796396","volume":"18","author":"JF Lechner","year":"1982","unstructured":"Lechner JF, Haugen A, McClendon IA, Pettis EW (1982) Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium. Vitro 18:633\u2013642","journal-title":"Vitro"},{"key":"379_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12890-020-1089-y","volume":"20","author":"C Lhommet","year":"2020","unstructured":"Lhommet C, Garot D, Grammatico-Guillon L, Jourdannaud C, Asfar P, Faisy C, Muller G, Barker KA, Mercier E, Robert S et al (2020) Predicting the microbial cause of community-acquired pneumonia: can physicians or a data-driven method differentiate viral from bacterial pneumonia at patient presentation?. BMC Pulm Med 20:62","journal-title":"BMC Pulm Med"},{"key":"379_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.drudis.2019.01.018","volume":"24","author":"C-C Li","year":"2019","unstructured":"Li C-C, Wang X-J, Wang H-CR (2019) Repurposing host-based therapeutics to control coronavirus and influenza virus. Drug Discov Today 24:726\u2013736","journal-title":"Drug Discov Today"},{"key":"379_CR39","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1096\/fj.10-158766","volume":"24","author":"C Luig","year":"2010","unstructured":"Luig C, K\u00f6ther K, Dudek SE, Gaestel M, Hiscott J, Wixler V, Ludwig S (2010) MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR. FASEB J 24:4068\u20134077","journal-title":"FASEB J"},{"key":"379_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep26742","volume":"6","author":"BM Marathe","year":"2016","unstructured":"Marathe BM, Wong S-S, Vogel P, Garcia-Alcalde F, Webster RG, Webby RJ, Najera I, Govorkova EA (2016) Combinations of oseltamivir and T-705 extend the treatment window for highly pathogenic influenza A(H5N1) Virus infection in mice. Sci Rep 6:26742","journal-title":"Sci Rep"},{"key":"379_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS (2020) Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun 11:102","journal-title":"Nat Commun"},{"key":"379_CR42","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1164\/rccm.201103-0395ED","volume":"183","author":"MA Matthay","year":"2011","unstructured":"Matthay MA, Liu KD (2011) Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. Am J Respir Crit Care Med 183:1127\u20131128","journal-title":"Am J Respir Crit Care Med"},{"key":"379_CR43","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00010.2008","volume":"295","author":"G Matute-Bello","year":"2008","unstructured":"Matute-Bello G, Frevert CW, Martin TR (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295:L379\u2013L399","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"379_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie PJ, Holmes S (2013) phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8:e61217","journal-title":"PLoS ONE"},{"key":"379_CR45","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, Binz T, Wegner A, Tallam A, Rausell A et al (2013) Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci USA 110:7820\u20137825","journal-title":"Proc Natl Acad Sci USA"},{"key":"379_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tips.2011.10.004","volume":"33","author":"KH M\u00fcller","year":"2012","unstructured":"M\u00fcller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE (2012) Emerging cellular targets for influenza antiviral agents. Trends Pharmacol Sci 33:89\u201399","journal-title":"Trends Pharmacol Sci"},{"key":"379_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2395-8","volume":"23","author":"Y-N Ni","year":"2019","unstructured":"Ni Y-N, Chen G, Sun J, Liang B-M, Liang Z-A (2019) The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care 23:99","journal-title":"Crit Care"},{"key":"379_CR48","doi-asserted-by":"publisher","first-page":"ltab013","DOI":"10.1093\/immadv\/ltab013","volume":"1","author":"SM O\u2019Carroll","year":"2021","unstructured":"O\u2019Carroll SM, O\u2019Neill LAJ (2021) Targeting immunometabolism to treat COVID-19. Immunother Adv 1:ltab013","journal-title":"Immunother Adv"},{"key":"379_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, Hait A, Hernaez B, Knudsen A, Iversen MB et al (2020) SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun 11:4938","journal-title":"Nat Commun"},{"key":"379_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553\u2013565","journal-title":"Nat Rev Immunol"},{"key":"379_CR51","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"EM P\u00e5lsson-McDermott","year":"2020","unstructured":"P\u00e5lsson-McDermott EM, O\u2019Neill LAJ (2020) Targeting immunometabolism as an anti-inflammatory strategy. Cell Res 30:300\u2013314","journal-title":"Cell Res"},{"key":"379_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41577-020-0391-5","volume":"21","author":"SR Paludan","year":"2021","unstructured":"Paludan SR, Pradeu T, Masters SL, Mogensen TH (2021) Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat Rev Immunol 21:137\u2013150","journal-title":"Nat Rev Immunol"},{"key":"379_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri.2017.139","volume":"18","author":"EJ Pearce","year":"2018","unstructured":"Pearce EJ, Pearce EL (2018) Immunometabolism in 2017: driving immunity: all roads lead to metabolism. Nat Rev Immunol 18:81\u201382","journal-title":"Nat Rev Immunol"},{"key":"379_CR54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/35060098","volume":"3","author":"S Pleschka","year":"2001","unstructured":"Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S (2001) Influenza virus propagation is impaired by inhibition of the Raf\/MEK\/ERK signalling cascade. Nat Cell Biol 3:301\u2013305","journal-title":"Nat Cell Biol"},{"key":"379_CR55","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Gl\u00f6ckner FO (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41:D590\u2013D596","journal-title":"Nucleic Acids Res"},{"key":"379_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.it.2017.08.006","volume":"39","author":"AS Rambold","year":"2018","unstructured":"Rambold AS, Pearce EL (2018) Mitochondrial dynamics at the interface of immune cell metabolism and function. Trends Immunol 39:6\u201318","journal-title":"Trends Immunol"},{"key":"379_CR57","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3389\/fmicb.2019.00962","volume":"10","author":"M Rao","year":"2019","unstructured":"Rao M, Dodoo E, Zumla A, Maeurer M (2019) Immunometabolism and pulmonary infections: implications for protective immune responses and host-directed therapies. Front Microbiol 10:962","journal-title":"Front Microbiol"},{"key":"379_CR58","first-page":"1904","volume":"48","author":"RR Reddel","year":"1988","unstructured":"Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC (1988) Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48:1904\u20131909","journal-title":"Cancer Res"},{"key":"379_CR59","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/jac\/dkq511","volume":"66","author":"A Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez A, D\u00edaz E, Mart\u00edn-Loeches I, Sandiumenge A, Canadell L, D\u00edaz JJ, Figueira JC, Marques A, Alvarez-Lerma F, Vall\u00e9s J et al (2011) Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 66:1140\u20131149","journal-title":"J Antimicrob Chemother"},{"key":"379_CR60","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.4049\/jimmunol.0804198","volume":"183","author":"M Schmolke","year":"2009","unstructured":"Schmolke M, Viemann D, Roth J, Ludwig S (2009) Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J Immunol 183:5180\u20135189","journal-title":"J Immunol"},{"key":"379_CR61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.antiviral.2018.07.006","volume":"157","author":"T Schr\u00e4der","year":"2018","unstructured":"Schr\u00e4der T, Dudek SE, Schreiber A, Ehrhardt C, Planz O, Ludwig S (2018) The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression. Antivir Res 157:80\u201392","journal-title":"Antivir Res"},{"key":"379_CR62","doi-asserted-by":"publisher","first-page":"16557","DOI":"10.1073\/pnas.2002828117","volume":"117","author":"A Schreiber","year":"2020","unstructured":"Schreiber A, Boff L, Anhlan D, Krischuns T, Brunotte L, Schuberth C, Wedlich-S\u00f6ldner R, Drexler H, Ludwig S (2020) Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes. Proc Natl Acad Sci USA 117:16557\u201316566","journal-title":"Proc Natl Acad Sci USA"},{"key":"379_CR63","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.csbj.2020.02.009","volume":"18","author":"F Scossa","year":"2020","unstructured":"Scossa F, Fernie AR (2020) The evolution of metabolism: How to test evolutionary hypotheses at the genomic level. Comput Struct Biotechnol J 18:482\u2013500","journal-title":"Comput Struct Biotechnol J"},{"key":"379_CR64","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1021\/acs.jmedchem.8b01683","volume":"62","author":"B Sethy","year":"2019","unstructured":"Sethy B, Hsieh C-F, Lin T-J, Hu P-Y, Chen Y-L, Lin C-Y, Tseng S-N, Horng J-T, Hsieh P-W (2019) Design, synthesis, and biological evaluation of itaconic acid derivatives as potential anti-influenza agents. J Med Chem 62:2390\u20132403","journal-title":"J Med Chem"},{"key":"379_CR65","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S, Osborn T, Terry KM, Levy MM (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:2235\u20132244","journal-title":"N Engl J Med"},{"key":"379_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010219","volume":"18","author":"A Sohail","year":"2022","unstructured":"Sohail A, Iqbal AA, Sahini N, Chen F, Tantawy M, Waqas SFH, Winterhoff M, Ebensen T, Schultz K, Geffers R et al (2022) Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog 18:e1010219","journal-title":"PLoS Pathog"},{"key":"379_CR67","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1111\/febs.15327","volume":"287","author":"G Soto-Heredero","year":"2020","unstructured":"Soto-Heredero G, G\u00f3mez de las Heras MM, Gaband\u00e9-Rodr\u00edguez E, Oller J, Mittelbrunn M (2020) Glycolysis\u2013a key player in the inflammatory response. FEBS J 287:3350\u20133369","journal-title":"FEBS J"},{"key":"379_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00011-016-0996-0","volume":"66","author":"LP Tavares","year":"2017","unstructured":"Tavares LP, Teixeira MM, Garcia CC (2017) The inflammatory response triggered by Influenza virus: a two edged sword. Inflamm Res 66:283\u2013302","journal-title":"Inflamm Res"},{"key":"379_CR69","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-4939-8678-1_17","volume":"1836","author":"AJW Te Velthuis","year":"2018","unstructured":"Te Velthuis AJW, Long JS, Barclay WS (2018) Assays to measure the activity of influenza virus polymerase. Methods Mol Biol 1836:343\u2013374","journal-title":"Methods Mol Biol"},{"key":"379_CR70","unstructured":"World Health Organization (2010) WHO guidelines for pharmacological management of pandemic influenza A (H1N1) 2009 and other influenza viruses. World Health Organization, Geneva"},{"key":"379_CR71","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1002\/ptr.6196","volume":"32","author":"Y-Q Yan","year":"2018","unstructured":"Yan Y-Q, Fu Y-J, Wu S, Qin H-Q, Zhen X, Song B-M, Weng Y-S, Wang P-C, Chen X-Y, Jiang Z-Y (2018) Anti-influenza activity of berberine improves prognosis by reducing viral replication in mice. Phytother Res 32:2560\u20132567","journal-title":"Phytother Res"},{"key":"379_CR72","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/microorganisms8071067","volume":"8","author":"J Yu","year":"2020","unstructured":"Yu J, Sun X, Goie JYG, Zhang Y (2020) Regulation of host immune responses against influenza A virus infection by mitogen-activated protein kinases (MAPKs). Microorganisms 8:1067","journal-title":"Microorganisms"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00379-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:45:31Z","timestamp":1779065131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00379-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,13]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00379-8","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MS-T and AG declared the deposit of a patent application related to the anti-influenza activity of\n                      cis\n                      -aconitate (reference: WO 2024126742).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}